FindTrial
Sign In

CLINICAL OUTCOME AND ITS CORRELATION WITH INFLAMMATORY MARKERS IN SARS COVID-19

CLINICAL OUTCOME AND ITS CORRELATION WITH INFLAMMATORY MARKERS IN SARS COVID-19 PATIENTS.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/08/035961
Enrollment
62
Registered
2021-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

maddali aravind surya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS OF BOTH SEXES AGE >18 PATIENTS TESTED POSITIVE FOR COVID-19 BY RTPCR

Exclusion criteria

Exclusion criteria: OTHER SYSTEMIC INFECTIONS INFLAMMATORY AND AUTO IMMUNE DISORDERS PATIENTS ON LONG TERM STEROID AND OTHER CYTOTOXIC DRUGS

Design outcomes

Primary

MeasureTime frame
DEATH DUE TO COVIDTimepoint: 1 year 6 months—

Secondary

MeasureTime frame
DURATION OF HOSPITAL STAY AND COMPLICATIONS OF COVIDTimepoint: 1 year 6 months—

Countries

India

Contacts

Public Contactmaddali aravind surya

Mahathma gandhi medical colleage and research institute

lokeshsdr@gmail.com8825481583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026